The Easy Trip IPO received total bids for 35.11 million shares against the 15 million on offer, according to data available with stock exchanges.The IPO comprises an offer for sale of Rs255 crore each by promoters Nishant Pitti and Rikant Pitti
The IPO is expected to value Deliveroo at more than $7 billion, based on a $180 million private funding round completed in January making it the biggest London IPO by market cap since Royal Mail in 2013
CAS9 Technology Market: Product Type (Consumables and Vectors), Application (Genome Engineering, Disease Models and In Vitro Genetic Depletion), Delivery Method (Physical Delivery Methods, Viral Delivery Methods and Non-Viral Delivery Methods) and End User (Biotechnology & Pharmaceutical Companies and Academic & Research Institutes) and Region - Global Forecast Till 2023overviewThe Global CAS9 Technology Market is growing with the rapid pace.According to a recent study report published by the Market Research Future, the Global CAS9 Technology Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace.It is also predicted that factors such as technological advancements in the field of genome editing will also drive the market growth in the coming future.Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/2064Competitive analysisCharacterized by the presence of several well-established and small players, the global market of CAS9 technology appears to be highly competitive and fragmented.International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.The intense competition prevalent in the market dictates the consolidation among marketers.Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.In October-16, CRISPR Therapeutics AG, a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, announced the pricing of its initial public offering of 4,000,000 common shares at a public offering price of USD 14.00 per share.In addition, CRISPR Therapeutics has granted the underwriters a 30-day option to purchase up to 600,000 additional common shares at the initial public offering price, less the underwriting discounts and commissions.
With rivals such as Grab and Gojek eyeing IPOs this year, competition is set to get tougher with the market giants and their war chests.
Aditya Birla Sun Life Asset Management has started talks with potential merchant bankers for the IPO, which is likely to be launched in the June quarter, said the people cited above
The unit felt it was appropriate to withdraw its listing due to recent changes in its name, business, and senior management team.
The company's Rs625 crore initial public offering was subscribed more than 83 times. The IPO comprised an offer-for-sale of up to 90.15 lakh equity shares and a fresh issue of ₹60 crore shares
The offer received bids for 74.56 million equity shares against the initial public offerings size of 7.26 million equity shares.The retail portion was subscribed 16.55 times and that of non-institutional investors 8.04 times
The UK food delivery giant chose the UK capital for its multibillion-dollar float.
High-growth hungry investors worrying you? Try hyperscalers! Snowflake has more than doubled its annual revenue in the last year but investors seem unimpressed with the $33bn IPO company's efforts.…
Happy Thursday! Welcome to another edition of Insider Retail, our weekly roundup of our top deep dives.
Oscar priced its IPO at $39 per share, selling more than 37 million shares $1 higher than its previously targeted offering range of $36-$38.
Plus, another alternative identifier in adtech emerges
Please visit Marketing Land for the full article.
The IPO comprises an offer for sale of ₹255 crore each by its promoters Nishant Pitti and Rikant Pitti. The listing will be on or around 19 March
The Chinese fintech firm working on a “short-term liquidity solution” for employees that's expected to take effect in April.
Policybazaar's other key investors include True North, Tencent, Tiger Global, Premji Invest, Temasek, Info Edge India Ltd and Ribbit Capital.Several existing investors in Policybazaar want to monetize some of their stakes in the company, while some investors may look for a complete exit via the IPO
Semrush is announcing an initial public offering of company stock, which will see the SEO software company selling shares on the New York Stock Exchange.The post Semrush to Publicly Sell Shares on New York Stock Exchange via @MattGSouthern appeared first on Search Engine Journal.
The initial public offering (IPO) comprises a fresh issue of shares aggregating up to ₹200 crore and an offer for sale of up to 21,340,931 equity shares from promoters and existing shareholders
But the company says changes in access to 3rd party data and cookies could really disrupt its business.
Please visit Search Engine Land for the full article.
The potential SPAC merger could value Bukalapak at about US$4 billion to US$5 billion.